hair loss from semaglutide Rapid weight can place stress on the body and trigger telogen effluvium- a temporary shedding phase. A 2024 study in JAAD reported ~0.8% of users experienced loss within 6 GLP-1 Hair Loss: How Wegovy,

Research is ongoing, but evidence remains preliminary

Documented Risk Areas The most consistently reported risk in the literature is hypoglycemia, a direct consequence of IGF-1 LR3s effect on cellular glucose uptake research models and supervised clinical settings alike flag blood sugar monitoring as a standard safeguard in study protocols

The improvement in HbA1c particularly noteworthy , as this biomarker is the most commonly used for diagnosing diabetes and prediabetes

[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Aron-Wisnewsky J., Warmbrunn M.V., Nieuwdorp M., Clment K

Data were analysed using one-way ANOVA with Bonferroni post hoc multiple-comparison test ( c h )